Isotonitazene (ISO)

A benzimidazole-class novel synthetic opioid (nitazene family) estimated at ~500x the potency of morphine at the mu-opioid receptor. First identified in European overdose deaths 2019; Schedule I US since April 2022. Not detected by standard opioid immunoassays; requires LC-MS/MS with nitazene-specific inclusion list.